Loading
Acute Lymphoblastic Leukemia Research · Journal article
Current Hematologic Malignancy Reports · August 11, 2026
Raises a question worth testing. It does not answer one.
This narrative review synthesizes existing molecular and epidemiologic evidence linking outdoor air pollution exposure to hematologic malignancies, identifying benzene and particulate matter as important pollutants and AML as the most strongly supported malignancy. The review raises mechanistic hypotheses and identifies research gaps but does not present new primary data or perform meta-analysis; it concludes that air pollution is a potentially modifiable risk factor, though further research is needed to establish causation and inform policy.
Narrative review. General population exposed to outdoor air pollution; disparate impacts on racial and ethnic minorities, low-income communities, and residents of rapidly industrializing regions.
Epidemiologic evidence is strongest for acute myeloid leukemia (AML), particularly with benzene exposure Acute lymphoblastic leukemia (ALL) associated with traffic-related pollution, NO₂, and PM exposure, though findings are less consistent Pollutants implicated include particulate matter (PM), benzene, nitrogen dioxide (NO₂), sulfur dioxide (SO₂), arsenic, and ethylene oxide
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should be aware that air pollution exposure, particularly benzene and particulate matter, may increase hematologic malignancy risk, especially for AML. This recognition may inform patient counseling, epidemiologic research, and support for environmental health advocacy, though individual risk prediction is not yet established.
A narrative review synthesizing molecular mechanisms and epidemiologic evidence across multiple pollutants and hematologic malignancies, without presenting new primary data or a quantitative meta-analysis, raising questions about causation rather than definitively answering them.
As stated by the source record.
Clinicians should be aware that air pollution exposure, particularly benzene and particulate matter, may increase hematologic malignancy risk, especially for AML. This recognition may inform patient counseling, epidemiologic research, and support for environmental health advocacy, though individual risk prediction is not yet established.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
PURPOSE OF REVIEW: Outdoor air pollution (OAP) is a major global environmental health threat associated with respiratory disease and solid tumors, with growing evidence linking it to hematologic malignancies. This review summarizes the molecular mechanisms and epidemiologic evidence connecting OAP exposure to acute and chronic leukemias, lymphomas, myelodysplastic syndromes (MDS), clonal hematopoiesis of indeterminate potential (CHIP), and multiple myeloma (MM). RECENT FINDINGS: Pollutants implicated in hematologic carcinogenesis include particulate matter (PM), benzene, nitrogen dioxide (NO₂), sulfur dioxide (SO₂), arsenic, and ethylene oxide. Molecular mechanisms include oxidative stress, DNA damage, epigenetic dysregulation, chronic inflammation, and hematopoietic stem cell dysfunction. Epidemiologic evidence is strongest for acute myeloid leukemia (AML), particularly with benzene exposure. Acute lymphoblastic leukemia (ALL) has also been associated with traffic-related pollution, NO₂, and PM exposure, though findings are less consistent. Certain lymphoma subtypes demonstrate pollutant-specific associations, while emerging evidence suggests possible links between OAP exposure and MDS and CHIP. In contrast, evidence for chronic leukemias and MM remains limited. Despite limitations, including exposure misclassification and residual confounding, cumulative molecular and epidemiologic evidence supports OAP as an important and potentially modifiable risk factor for hematologic malignancies. OAP exposure disproportionately affects racial and ethnic minorities, low-income communities, and rapidly industrializing regions, magnifying existing health disparities. Further research, environmental policy reform, and public health interventions are needed to reduce exposure and disease burden.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.